Skip to main content

The Low-Down on AACC

Our sister blog, The Sample, is hard at work covering the AACC annual meeting. Kirell Lakhman has a series of posts up and from Friday's session, he writes about new molecular techs flocking to pharma and linking oxaliplatin toxicity to the glutathione S-transferase gene. Yesterday, Lakhman blogged about what molecular diagnostic labs should keep in mind when trying to quantify serum tumor markers using LC-MS/MS and how revamping the US health care system may affect clinical labs. Lakhman is also noting interesting quotes he's heard, such as the University of Washington's Andrew Hoofnagle saying the software bundle to a mass spec "can be testy at times." If you've heard anything good, let him know.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.